Long-acting drug delivery formulations enable sustained and prolonged drug release at the site of action or for systemic delivery, overcoming the need for frequent and repeated drug administration. This Review discusses US Food and Drug Administration (FDA)-approved long-acting drug delivery formulations, highlighting different slow-release mechanisms and delivery platforms, and the materials used to achieve them.
- Wei Li
- Jie Tang
- Mark R. Prausnitz
